Asensus Surgical Inc (ASXC) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Asensus Surgical Inc   (NYSE: ASXC)
 

Asensus Surgical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2024, Asensus Surgical Inc 's inventory turnover ratio sequentially decreased to 1.67 in the second quarter 2024, otherwise the ratio remained above the average, as ASXC's markets remain strong.Asensus Surgical Inc 's average inventory processing period in the Jun 30 2024 quarter, has increased to 219 days, from 215 days, in the Mar 31 2024 quarter.

Within Healthcare sector 262 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1197 in the first quarter 2024, to 1662.

ASXC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Asensus Surgical Inc Market Share?

What is Inventory Turnover Ratio?




ASXC Inventory Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Inventory Growth -21.17 % -32.63 % -13.42 % -26.03 % 7.48 %
Y / Y Cost of Sales Growth -33.33 % 1.8 % 85.6 % -54.59 % 27.82 %
Inventory Turnover Ratio (TTM) 1.67 1.7 1.54 1.25 1.44
ASXC's Total Ranking # 1662 # 1197 # 1384 # 1282 #
Average inventory processing period 218 215 237 293 254
Seq. Inventory Growth 20.17 % -16.93 % 7.32 % -26.42 % 2.7 %
Seq. Cost of Sales Growth -33.33 % -29.66 % 113.25 % -33.33 % 1.8 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 263
Overall Market # 1662

Inventory Turnover Ratio Statistics
High Average Low
3.94 1.34 0.5
(Jun 30 2014)   (Dec 31 2020)




Financial Statements
Asensus Surgical Inc 's Inventories $ 7 Millions Visit ASXC's Balance sheet
Asensus Surgical Inc 's Cost of Revenues TTM $ 11 Millions Visit ASXC's Income Statement
What are ASXC's Sales? Visit ASXC's Sales by Segment

Other Inventory Turnover Ratios
Asensus Surgical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ASXC's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ASXC's Competitors
Inventory Turnover Ratio for ASXC's Suppliers
Inventory Turnover Ratio for ASXC's Customers

You may also want to know
ASXC's Sales Growth Rates ASXC's Pe Price to earnings ratio ASXC's Receivables Turnover Ratio ASXC's Stock Quote
ASXC's Net Income Growth Rates ASXC's Ps Price to Sales ratio ASXC's Sales per Employee ASXC's Asset Turnover Ratio
ASXC's Net Margin ASXC's Pb Price to Book ratio ASXC's Financial Strength Ratios ASXC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
West Pharmaceutical Services Inc   4.31 $ 1,849.300  Millions$ 429  Millions
Escalon Medical Corp   4.31 $ 6.835  Millions$ 2  Millions
Envista Holdings Corporation  4.31 $ 1,150.700  Millions$ 267  Millions
Steris Plc  4.27 $ 3,085.440  Millions$ 722  Millions
Lifeward ltd   4.25 $ 15.819  Millions$ 4  Millions
Align Technology inc   4.20 $ 1,188.507  Millions$ 283  Millions
Electromedical Technologies Inc   4.18 $ 0.290  Millions$ 0  Millions
Ge Healthcare Technologies Inc   4.13 $ 8,356.000  Millions$ 2,025  Millions
Bristol myers Squibb Company  4.10 $ 11,450.000  Millions$ 2,790  Millions
Ufp Technologies Inc   4.10 $ 298.948  Millions$ 73  Millions
Integrated Biopharma Inc  4.08 $ 46.000  Millions$ 11  Millions
Organogenesis Holdings Inc   4.06 $ 112.420  Millions$ 28  Millions
Avid Bioservices Inc   4.02 $ 133.460  Millions$ 33  Millions
Blue Water Vaccines Inc  3.93 $ 2.301  Millions$ 1  Millions
Dynatronics Corporation  3.93 $ 24.899  Millions$ 6  Millions
Strata Skin Sciences Inc  3.90 $ 13.821  Millions$ 4  Millions
Idexx Laboratories Inc  3.88 $ 1,498.526  Millions$ 386  Millions
Exelixis Inc   3.78 $ 79.450  Millions$ 21  Millions
Incyte Corporation  3.76 $ 267.432  Millions$ 71  Millions
Catalyst Pharmaceuticals Inc   3.70 $ 57.901  Millions$ 16  Millions
Gilead Sciences Inc   3.68 $ 6,751.000  Millions$ 1,832  Millions
Teva Pharmaceutical Industries Limited  3.65 $ 8,227.000  Millions$ 2,256  Millions
3m Company  3.64 $ 17,158.000  Millions$ 4,711  Millions
Tactile Systems Technology Inc   3.62 $ 77.622  Millions$ 21  Millions
Lftd Partners Inc   3.59 $ 31.422  Millions$ 9  Millions
Becton Dickinson And Company  3.52 $ 11,488.000  Millions$ 3,265  Millions
Cadre Holdings inc   3.51 $ 311.529  Millions$ 89  Millions
Novocure Limited  3.37 $ 132.991  Millions$ 39  Millions
Koru Medical Systems Inc   3.33 $ 11.561  Millions$ 3  Millions
Logicmark Inc  3.32 $ 3.221  Millions$ 1  Millions

Date modified: 2026-08-29T17:23:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.